The Danish biotech startup Enduro Genetics (“Enduro”) has raised EUR 12m in a series-A investment round led by Supernova Invest, NOON Ventures and Sandwater.
Enduro is a deeptech synthetic biology company redefining bioprocesses with a new optimisation technology that unlocks the full potential of biotechnology by boosting already high-performing processes.
The company has developed a genetic plugin that connects high production levels to growth, which effectively makes the production strain “addicted” to production of the desired product. The new funding allows Enduro to expand its platform and to commercialise its technology.
Enduro was formed in 2019 and has, since then, been working on innovating biomanufacturing by addressing the challenge of microbial productivity.
Accura advised Enduro in connection with the investment.